Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1994 May;32(5):1364–1365. doi: 10.1128/jcm.32.5.1364-1365.1994

Comparison of agar dilution, tube dilution, and broth microdilution susceptibility tests for determination of ramoplanin MICs.

M T Kenny 1, M A Brackman 1
PMCID: PMC263704  PMID: 8051270

Abstract

Standard broth microdilution (with and without bovine serum albumin [BSA] supplementation), tube dilution, and agar dilution susceptibility tests were compared for determining ramoplanin MICs. With a data base of 246 clinical isolates of gram-positive bacteria from 33 U.S. sites, it was shown that (i) agar and tube dilution susceptibility tests gave essentially the same results (93.9% of the test results were within 1 doubling dilution of equivalence), (ii) broth microdilution susceptibility tests gave results up to 5 doubling dilutions higher than agar or tube assays, and (iii) this data skewing could be reversed by BSA supplementation (final concentration, 0.02%) of the broth microdilution test medium.

Full text

PDF
1364

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barry A. L., Pfaller M. A., Fuchs P. C. Ramoplanin susceptibility testing criteria. J Clin Microbiol. 1993 Jul;31(7):1932–1935. doi: 10.1128/jcm.31.7.1932-1935.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ciabatti R., Kettenring J. K., Winters G., Tuan G., Zerilli L., Cavalleri B. Ramoplanin (A-16686), a new glycolipodepsipeptide antibiotic. III. Structure elucidation. J Antibiot (Tokyo) 1989 Feb;42(2):254–267. doi: 10.7164/antibiotics.42.254. [DOI] [PubMed] [Google Scholar]
  3. Collins L. A., Eliopoulos G. M., Wennersten C. B., Ferraro M. J., Moellering R. C., Jr In vitro activity of ramoplanin against vancomycin-resistant gram-positive organisms. Antimicrob Agents Chemother. 1993 Jun;37(6):1364–1366. doi: 10.1128/aac.37.6.1364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Jones R. N., Barry A. L. In vitro evaluation of ramoplanin (A16686 or MDL62198). A new depsipeptide complex for potential topical use. Diagn Microbiol Infect Dis. 1989 May-Jun;12(3):279–282. doi: 10.1016/0732-8893(89)90029-1. [DOI] [PubMed] [Google Scholar]
  5. Lawrence T., Rotstein C., Beam T. R., Jr, Gorzynski E. A., Amsterdam D. In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of gram-positive cocci. Antimicrob Agents Chemother. 1993 Apr;37(4):896–900. doi: 10.1128/aac.37.4.896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Scotti R., Dulworth J. K., Kenny M. T., Goldstein B. P. Effect of protein on ramoplanin broth microdilution minimum inhibitory concentrations. Diagn Microbiol Infect Dis. 1993 Oct;17(3):209–211. doi: 10.1016/0732-8893(93)90098-r. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES